HUP9901890A2 - Gyógyszer és eljárás szervezet gyógyszeres kezelésére - Google Patents

Gyógyszer és eljárás szervezet gyógyszeres kezelésére

Info

Publication number
HUP9901890A2
HUP9901890A2 HU9901890A HUP9901890A HUP9901890A2 HU P9901890 A2 HUP9901890 A2 HU P9901890A2 HU 9901890 A HU9901890 A HU 9901890A HU P9901890 A HUP9901890 A HU P9901890A HU P9901890 A2 HUP9901890 A2 HU P9901890A2
Authority
HU
Hungary
Prior art keywords
active pharmaceutical
pharmaceutical ingredient
medicinal preparation
initial
chemical composition
Prior art date
Application number
HU9901890A
Other languages
English (en)
Inventor
Oleg Iliich Epshtein
Original Assignee
Oleg Iliich Epshtein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from RU96102195A external-priority patent/RU2101000C1/ru
Priority claimed from RU96102209A external-priority patent/RU2084217C1/ru
Priority claimed from RU96107564/14A external-priority patent/RU2142794C1/ru
Application filed by Oleg Iliich Epshtein filed Critical Oleg Iliich Epshtein
Publication of HUP9901890A2 publication Critical patent/HUP9901890A2/hu
Publication of HUP9901890A3 publication Critical patent/HUP9901890A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A találmány szerinti gyógyászati készítmény (gyógyszer) aktívgyógyszerhatóanyagőt tartalmaz terápiás adagban egy pőtencírőzőttgyógyászati készítményről biőenergetikai útőn átvitt infőrmációthőrdőzó vívőanyagként; a pőtencírőzőtt gyógyászati készítménythőmeőpátiás eljárásőkkal állítják elő, és kezdeti (kiindűlási) kémiaiösszetétele az aktív gyógyszerhatóanyag összetételével azőnős. Atalálmány előnyös megvalósítási főrmájában a gyógyászati készítményalapja egy aktív gyógyszerhatóanyagőt terápiás adagban tartalmazóvívőanyag (hőrdőzóanyag), és ezzel van kőmbinálva (beépítés, őldásvagy bekeveredés útján) egy hőmepátiás eljárásőkkal előállítőtt,pőtencírőzőtt gyógyászati készítmény. Ez űtóbbi készítmény kiindűlásikémiai összetétele a terápiás dózisban lévő aktív gyógyszerhatóanyagkémiai összetételével azőnős. ŕ
HU9901890A 1996-02-12 1997-02-10 Medicament and method of treating an organism with medicaments HUP9901890A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU96102195A RU2101000C1 (ru) 1996-02-12 1996-02-12 Лекарственное средство
RU96102209A RU2084217C1 (ru) 1996-02-12 1996-02-12 Лекарственное средство
RU96107564/14A RU2142794C1 (ru) 1996-04-24 1996-04-24 Способ воздействия на организм лечебными средствами и лекарственное средство

Publications (2)

Publication Number Publication Date
HUP9901890A2 true HUP9901890A2 (hu) 1999-10-28
HUP9901890A3 HUP9901890A3 (en) 2001-04-28

Family

ID=27354169

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9901890A HUP9901890A3 (en) 1996-02-12 1997-02-10 Medicament and method of treating an organism with medicaments

Country Status (14)

Country Link
US (1) US8178498B1 (hu)
EP (1) EP0884042A4 (hu)
JP (1) JPH11509452A (hu)
KR (1) KR19990082461A (hu)
CN (1) CN1141929C (hu)
AU (1) AU723812B2 (hu)
BR (1) BR9707418A (hu)
CA (1) CA2251617A1 (hu)
EA (1) EA000885B1 (hu)
HU (1) HUP9901890A3 (hu)
IL (1) IL125743A (hu)
PL (1) PL188153B1 (hu)
UA (1) UA32457C2 (hu)
WO (1) WO1997028776A1 (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (ru) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
RU2201255C1 (ru) 2001-12-26 2003-03-27 Эпштейн Олег Ильич Лекарственное средство и способ регуляции сосудистого тонуса
UA76639C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
UA76638C2 (en) 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
AU2009201723B2 (en) * 2003-02-28 2014-11-27 Birseck Pty Ltd Method of Treatment
RU2253478C1 (ru) * 2003-10-01 2005-06-10 Эпштейн Олег Ильич Средство для потенцирования лечебных эффектов - усиления действия лекарственного вещества
RU2309732C1 (ru) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
CA2654408C (en) 2006-06-06 2018-05-08 Oleg Iliich Epshtein Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance
CA2711839A1 (en) * 2008-01-22 2009-04-30 Reinhard Michael Kuzeff Method of treatment with potentised stereoisomer of glutamate
DE112011102362T5 (de) 2010-07-15 2013-04-25 Oleg Iliich Epshtein Pharmazeutische Kombinationszusammensetzung und Verfahren zur Behandlung von Erkrankungen oder Zuständen, die mit neurodegenerativen Erkrankungen in Verbindung stehen
EA030542B1 (ru) 2010-07-15 2018-08-31 Олег Ильич ЭПШТЕЙН Комбинированная фармацевтическая композиция и способ лечения заболеваний или состояний желудочно-кишечного тракта функциональной этиологии
EA030566B1 (ru) 2010-07-15 2018-08-31 Олег Ильич ЭПШТЕЙН Способ повышения терапевтической эффективности активированной-потенцированной формы антитела к эндогенной биомолекуле и фармацевтическая композиция
ITTO20110641A1 (it) 2010-07-15 2012-01-16 Oleg Iliich Epshtein Composizioni farmaceutiche e metodi di trattamento
ITTO20110632A1 (it) 2010-07-21 2012-01-22 Oleg Iliich Epshtein Metodo per trattare il disturbo da deficit di attenzione e iperattivita'
CA2805978C (en) 2010-07-21 2016-06-28 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
RU2013111962A (ru) * 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
RU2013111961A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB750155A (en) * 1953-03-17 1956-06-13 Nat Res Dev Substituted alanines
US3134718A (en) * 1963-12-12 1964-05-26 Schering Corp Pregna-1,4-dienes and compositions containing same
US3901967A (en) * 1973-09-10 1975-08-26 Union Corp Sustained release of atropine
SE393532B (sv) * 1974-05-02 1977-05-16 Draco Ab Sett att framstella en farmaceutisk zinkberedning for astadkommande av en smaklig, fordragbar, peroral zinklosning innehallande ett zinkkomplex
DE2810344A1 (de) 1978-03-10 1979-09-13 Dieter Dr Med Aschoff Vorrichtung zur gleichstromwiderstandsmessung an den akupunkturpunkten von menschen oder tieren sowie verwendung der vorrichtung fuer nicht therapeutische und nicht diagnostische zwecke und verfahren zur unterscheidung von stoffen und zur ermittlung ihrer eignung fuer und ihrer einfluesse auf menschen und tiere
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
US4839341A (en) * 1984-05-29 1989-06-13 Eli Lilly And Company Stabilized insulin formulations
US4987127A (en) * 1989-01-31 1991-01-22 Dal Sirany Method of treating a virus outbreak
RU2007989C1 (ru) 1991-11-12 1994-02-28 Акционерное общество "Трейдис" Способ габович подбора гомеопатических препаратов и их разовой дозы
RU2035167C1 (ru) 1992-07-16 1995-05-20 Гальцев Юрий Викторович Способ получения биологически активного водного раствора меда
IES930215A2 (en) * 1993-03-22 1993-08-11 Maitreya Corp Ltd A homeopathic medicine
RU2033784C1 (ru) 1993-05-28 1995-04-30 Индивидуальное частное предприятие "Диалог" Устройство для репродуцирования гомеопатических и изопатических препаратов
RU2042349C1 (ru) 1994-03-02 1995-08-27 Наталья Борисовна Зубова Устройство для записи информационного сигнала о биологически активном веществе на носитель
US5629286A (en) 1994-03-31 1997-05-13 Brewitt; Barbara Homeopathic dilutions of growth factors
IL110035A0 (en) * 1994-06-16 1994-10-07 Tapuach Natural Technologies 1 Homeopathic formulations

Also Published As

Publication number Publication date
PL188153B1 (pl) 2004-12-31
HUP9901890A3 (en) 2001-04-28
KR19990082461A (ko) 1999-11-25
UA32457C2 (uk) 2000-12-15
CN1211175A (zh) 1999-03-17
CA2251617A1 (en) 1997-08-14
US8178498B1 (en) 2012-05-15
BR9707418A (pt) 1999-05-25
AU1816097A (en) 1997-08-28
AU723812B2 (en) 2000-09-07
EP0884042A1 (en) 1998-12-16
EA199800636A1 (ru) 2000-02-28
IL125743A0 (en) 1999-04-11
EP0884042A4 (en) 2006-01-04
WO1997028776A1 (fr) 1997-08-14
CN1141929C (zh) 2004-03-17
PL328349A1 (en) 1999-01-18
JPH11509452A (ja) 1999-08-24
IL125743A (en) 2003-09-17
EA000885B1 (ru) 2000-06-26

Similar Documents

Publication Publication Date Title
HUP9901890A2 (hu) Gyógyszer és eljárás szervezet gyógyszeres kezelésére
IT1261849B (it) Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
HUP9904094A2 (hu) Protonpumpa inhibitort és prokinetikus szert tartalmazó orális gyógyszer-adagolási formák
IS1694B (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
GEP20053595B (en) Cyclopentanoindoles, Compositions Containing Such Compounds and Methods of Treatment
DE69527842T2 (de) Oral anzuwendendes flüssiges arzneimittel enthaltend alendronat
GEP20043216B (en) Orally Administered Controlled Drug Delivery System
ATE235895T1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
NO171365C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
CA2068324A1 (en) Metal-peptide compositions and methods for stimulating hair growth
CA2066403A1 (en) Transmucosal dosage form
KR950700056A (ko) 분무-냉각된 나부메톤(Spray-chilled nabumetone)
ES2171469T3 (es) Composicion administrada por via nasal y preparacion que la contiene.
DE60126433D1 (de) Prozess zur herstellung von pharmazeutischen zusammensetzungen zur verwendung mit weichgelatine formulierungen
GEP19991686B (en) Pharmaceutical Composition for Obtaining Effervescent Powder or Tablet, Pharmaceutical Preparation and Method for Preparing Same
AU1935788A (en) A process for producing an administration and/or dosage form for medically active ingredients of drugs
IL108071A0 (en) Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines their preparation and pharmaceutical compositions containing them
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
UY25192A1 (es) Formulación medicamentosa con liberación controlada de sustancia activa
KR970032872A (ko) 아세틸살리실산을 함유하는 피부 손상 처치용 약물
ATE295157T1 (de) Mittel zur transdermalen verabreichung von arzneistoffen
ATE454139T1 (de) Arzneimittel mit shikonin als wirkstoff
CO4520283A1 (es) Agentes antivirales
AR002727A1 (es) El uso de ridogrel para la fabricacion de un medicamento util para el tratamiento de enfermedades digestivas inflamatorias, una composicionfarmaceutica que comprende ridogrel y un procedimiento para preparar dicha composicion.
ATE293445T1 (de) Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees